España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Legend Biotech
LEGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$37.69
0.25
0.67%
At close: -
$37.69
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Legend Biotech (LEGN) Forecast
News
Earnings
Legend Biotech (LEGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Legend Biotech (NASDAQ:LEGN) Stock
Legend Biotech Stock (NASDAQ: LEGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 23, 2025
Where Legend Biotech Stands With Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Tuesday, January 21, 2025
Legend Biotech shares are trading higher. HC ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Friday, January 10, 2025
Watching Legend Biotech; Shares Spike Higher ...
Benzinga Newsdesk
Monday, December 30, 2024
Breaking Down Legend Biotech: 9 Analysts Share Their Views
Benzinga Insights
Piper Sandler Reiterates Overweight on Legend...
Benzinga Newsdesk
Monday, December 23, 2024
Legend Biotech Corp Announces Resignation Of ...
Benzinga Newsdesk
Monday, December 16, 2024
(LEGN) - Analyzing Legend Biotech's Short Interest
Benzinga Insights
Tuesday, December 10, 2024
Deep Dive Into Legend Biotech Stock: Analyst Perspectives (10 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Reported Earlier, Legend Biotech CARVYKTI Del...
Benzinga Newsdesk
Monday, December 09, 2024
Cantor Fitzgerald Reiterates Overweight on Le...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Legend B...
Benzinga Newsdesk
Wednesday, November 13, 2024
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Legend Biotech Q3 2024 GAAP EPS $(0.34) Beats...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Tuesday, November 05, 2024
Legend Biotech To Present Key MRD Data From P...
Benzinga Newsdesk
Tuesday, October 29, 2024
RBC Capital Reiterates Outperform on Legend B...
Benzinga Newsdesk
Wednesday, October 16, 2024
9 Analysts Have This To Say About Legend Biotech
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Tuesday, October 08, 2024
Redburn Atlantic Initiates Coverage On Legend...
Benzinga Newsdesk
Friday, October 04, 2024
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Thursday, October 03, 2024
Legend Biotech Establishes New Research And D...
Benzinga Newsdesk
Monday, September 30, 2024
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Friday, September 27, 2024
Johnson & Johnson And Legend Biotech Corp An...
Benzinga Newsdesk
Where Legend Biotech Stands With Analysts
Benzinga Insights
RBC Capital Reiterates Outperform on Legend B...
Benzinga Newsdesk
Tuesday, September 24, 2024
Multiply Labs With Legend Biotech Announces A...
Benzinga Newsdesk
Friday, September 06, 2024
Peering Into Legend Biotech's Recent Short Interest
Benzinga Insights
Wednesday, August 28, 2024
Beyond The Numbers: 14 Analysts Discuss Legend Biotech Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Tuesday, August 27, 2024
Legend Biotech Receives Approval From China N...
Benzinga Newsdesk
Friday, August 16, 2024
Looking Into Legend Biotech's Recent Short Interest
Benzinga Insights
Monday, August 12, 2024
Beyond The Numbers: 15 Analysts Discuss Legend Biotech Stock
Benzinga Insights
RBC Capital Reiterates Outperform on Legend B...
Benzinga Newsdesk
Legend BioTech shares are trading higher. Sco...
Benzinga Newsdesk
Scotiabank Maintains Sector Outperform on Leg...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Friday, August 09, 2024
Legend Biotech shares are trading higher afte...
Benzinga Newsdesk
Legend Biotech Q2 EPS $(0.05) Beats $(0.38) E...
Benzinga Newsdesk
Thursday, August 01, 2024
Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation?
The Bamboo Works
Friday, July 26, 2024
Legend Biotech Reports Preliminary Results; E...
Benzinga Newsdesk
Sunday, July 21, 2024
Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?
Lekha Gupta
Thursday, July 18, 2024
Scotiabank Maintains Sector Outperform on Leg...
Benzinga Newsdesk
Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Monday, July 15, 2024
The Latest Analyst Ratings For Legend Biotech
Benzinga Insights
TD Cowen Maintains Buy on Legend Biotech, Low...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
